Study Summary
This trial is testing whether an online program called LEAF can reduce burden and increase well-being in Alzheimer's caregivers. There are two methods of delivery being compared, and the results will be compared to a control group. If the program is effective, it could be made available to Alzheimer caregivers across the country.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
3 Primary · 1 Secondary · Reporting Duration: Measures will be taken at 13 months.
Month 13
Caregiver Burden
Caregiver Mastery
PROMIS-Anxiety
PROMIS-Depression
Psychological Well-Being
Trial Safety
Safety Progress
Trial Design
3 Treatment Groups
Emotion Reporting Control
1 of 3
Facilitated Intervention
1 of 3
Self-Guided Intervention
1 of 3
Active Control
Experimental Treatment
500 Total Participants · 3 Treatment Groups
Primary Treatment: LEAF Positive Emotion Intervention · No Placebo Group · N/A
Facilitated Intervention
Behavioral
Experimental Group · 1 Intervention: LEAF Positive Emotion Intervention · Intervention Types: BehavioralSelf-Guided Intervention
Behavioral
Experimental Group · 1 Intervention: LEAF Positive Emotion Intervention · Intervention Types: BehavioralEmotion Reporting Control
Other
ActiveComparator Group · 1 Intervention: Emotion Reporting Control Condition · Intervention Types: OtherTrial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: measures will be taken at 13 months.
Who is running the clinical trial?
Northwestern UniversityLead Sponsor
1,455 Previous Clinical Trials
789,194 Total Patients Enrolled
University of California, San FranciscoOTHER
2,283 Previous Clinical Trials
11,577,245 Total Patients Enrolled
Judith Moskowitz, PhDPrincipal Investigator - Northwestern University
Northwestern University
1 Previous Clinical Trials
1,000 Total Patients Enrolled
Eligibility Criteria
Age 18+ · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:You are 18 or older and identify as the primary caregiver of a family member with Alzheimer's disease or probable Alzheimer's.
You are not a resident of a care facility.
You must speak and read English.
Who else is applying?
What state do they live in?
| Illinois | 100.0% |
What site did they apply to?
| Northwestern University | 100.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 100.0% |
How many prior treatments have patients received?
| 0 | 100.0% |
How responsive is this trial?
Typically responds via
| 100.0% | |
Most responsive sites:
- Northwestern University: < 48 hours
Average response time
- < 2 Days
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments